These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33307026)

  • 1. Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies.
    Kim ES; Tarassishin L; Eisele C; Barre A; Nair N; Rendon A; Hawkins K; Debebe A; White S; Thjømøe A; Mørk E; Bento-Miranda M; Panchal H; Agrawal M; Patel A; Chen CL; Kornbluth A; George J; Legnani P; Maser E; Loudon H; Mella MT; Stone J; Dubinsky M; Sabino J; Torres J; Colombel JF; Peter I; Hu J;
    Gastroenterology; 2021 Mar; 160(4):1118-1130.e3. PubMed ID: 33307026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
    Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
    Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease.
    Tandon P; Lee EY; Maxwell C; Hitz L; Ambrosio L; Dieleman L; Halloran B; Kroeker K; Huang VM
    Dig Dis Sci; 2021 May; 66(5):1639-1649. PubMed ID: 32533542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice.
    Torres J; Hu J; Seki A; Eisele C; Nair N; Huang R; Tarassishin L; Jharap B; Cote-Daigneault J; Mao Q; Mogno I; Britton GJ; Uzzan M; Chen CL; Kornbluth A; George J; Legnani P; Maser E; Loudon H; Stone J; Dubinsky M; Faith JJ; Clemente JC; Mehandru S; Colombel JF; Peter I
    Gut; 2020 Jan; 69(1):42-51. PubMed ID: 31036757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.
    Mumolo MG; Bertani L; Ceccarelli L; Laino G; Di Fluri G; Albano E; Tapete G; Costa F
    World J Gastroenterol; 2018 Sep; 24(33):3681-3694. PubMed ID: 30197475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
    Julsgaard M; Hvas CL; Gearry RB; Vestergaard T; Fallingborg J; Svenningsen L; Kjeldsen J; Sparrow MP; Wildt S; Kelsen J; Bell SJ
    Inflamm Bowel Dis; 2017 Jul; 23(7):1240-1246. PubMed ID: 28498159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.
    Henderson P; Casey A; Lawrence SJ; Kennedy NA; Kingstone K; Rogers P; Gillett PM; Wilson DC
    Am J Gastroenterol; 2012 Jun; 107(6):941-9. PubMed ID: 22370604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists.
    Tursi A; Elisei W; Picchio M; Giorgetti G; Brandimarte G
    Dig Dis Sci; 2015 May; 60(5):1406-13. PubMed ID: 25445163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M
    Dig Dis Sci; 2017 Nov; 62(11):3123-3130. PubMed ID: 28948412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study.
    Ferreiro-Iglesias R; Barreiro-de Acosta M; Lorenzo-Gonzalez A; Dominguez-Muñoz JE
    J Clin Gastroenterol; 2018 Mar; 52(3):229-234. PubMed ID: 27984399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease.
    Sabino J; Tarassishin L; Eisele C; Hawkins K; Barré A; Nair N; Rendon A; Debebe A; Picker M; Agrawal M; Stone J; George J; Legnani P; Maser E; Chen CL; Thjømøe A; Mørk E; Dubinsky M; Hu J; Colombel JF; Peter I; Torres J
    J Crohns Colitis; 2023 Nov; 17(11):1723-1732. PubMed ID: 37279927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
    Rokkas T; Portincasa P; Koutroubakis IE
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):299-306. PubMed ID: 30240474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumab.
    Orfanoudaki E; Drygiannakis I; Theodoraki E; Foteinogiannopoulou K; Mantaka A; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e777-e782. PubMed ID: 34284415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
    Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN
    Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.
    Rosenfeld G; Greenup AJ; Round A; Takach O; Halparin L; Saadeddin A; Ho JK; Lee T; Enns R; Bressler B
    World J Gastroenterol; 2016 Sep; 22(36):8211-8. PubMed ID: 27688663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.
    Mahadevan U; Long MD; Kane SV; Roy A; Dubinsky MC; Sands BE; Cohen RD; Chambers CD; Sandborn WJ;
    Gastroenterology; 2021 Mar; 160(4):1131-1139. PubMed ID: 33227283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.